TRYGAPOCE Trademark

Trademark Overview


On Monday, October 16, 2023, a trademark application was filed for TRYGAPOCE with the United States Patent and Trademark Office. The USPTO has given the TRYGAPOCE trademark a serial number of 98225245. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 10, 2024. This trademark is owned by Ionis Pharmaceuticals, Inc.. The TRYGAPOCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the field of genetic diseases and disorders; providing medical and scientific research and medical and scientific research information in the field of genetic diseases and disorders; compiling data for research purposes in the field of genetic diseases and disorders; pharmaceutical research and development in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; providing medical and scientific research and medical and scientific research information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; compiling data for research purposes in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders
trygapoce

General Information


Serial Number98225245
Word MarkTRYGAPOCE
Filing DateMonday, October 16, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2024

Trademark Statements


Goods and ServicesPharmaceutical research and development in the field of genetic diseases and disorders; providing medical and scientific research and medical and scientific research information in the field of genetic diseases and disorders; compiling data for research purposes in the field of genetic diseases and disorders; pharmaceutical research and development in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; providing medical and scientific research and medical and scientific research information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; compiling data for research purposes in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 23, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIonis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010

Party NameIonis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010

Trademark Events


Event DateEvent Description
Thursday, October 19, 2023NEW APPLICATION ENTERED
Sunday, June 2, 2024ASSIGNED TO EXAMINER
Wednesday, June 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 23, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 26, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 25, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 25, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 10, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 25, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED